Literature DB >> 17360957

PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages.

Kate Schroder1, Monika Lichtinger, Katharine M Irvine, Kristian Brion, Angela Trieu, Ian L Ross, Timothy Ravasi, Katryn J Stacey, Michael Rehli, David A Hume, Matthew J Sweet.   

Abstract

Macrophages are activated by unmethylated CpG-containing DNA (CpG DNA) via TLR9. IFN-gamma and LPS can synergize with CpG DNA to enhance proinflammatory responses in murine macrophages. Here, we show that LPS and IFN-gamma up-regulated Tlr9 mRNA in murine bone marrow-derived macrophages (BMM). The ability of LPS and IFN-gamma to induce Tlr9 mRNA expression in BMM was dependent on the presence of the growth factor, CSF-1, which is constitutively present in vivo. However, there were clear differences in mechanisms of Tlr9 mRNA induction. LPS stimulation rapidly removed the CSF-1 receptor (CSF-1R) from the cell surface, thereby blocking CSF-1-mediated transcriptional repression and indirectly inducing Tlr9 mRNA expression. By contrast, IFN-gamma activated the Tlr9 promoter directly and only marginally affected cell surface CSF-1R expression. An approximately 100-bp proximal promoter of the murine Tlr9 gene was sufficient to confer basal and IFN-gamma-inducible expression in RAW264.7 cells. A composite IFN regulatory factor (IRF)/PU.1 site upon the major transcription start site was identified. Mutation of the binding sites for PU.1 or IRF impaired basal promoter activity, but only the IRF-binding site was required for IFN-gamma induction. The mRNA expression of the IRF family member IFN consensus-binding protein [(ICSBP)/IRF8] was coregulated with Tlr9 in macrophages, and constitutive and IFN-gamma-inducible Tlr9 mRNA expression was reduced in ICSBP-deficient BMM. This study therefore characterizes the regulation of mouse Tlr9 expression and defines a molecular mechanism by which IFN-gamma amplifies mouse macrophage responses to CpG DNA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360957     DOI: 10.1189/jlb.0107036

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  22 in total

Review 1.  Transcriptional programming of the dendritic cell network.

Authors:  Gabrielle T Belz; Stephen L Nutt
Journal:  Nat Rev Immunol       Date:  2012-01-25       Impact factor: 53.106

2.  JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis.

Authors:  Katja Denninger; Susanne Rasmussen; Jeppe Madura Larsen; Catrine Orskov; Steen Seier Poulsen; Poul Sørensen; Jan Pravsgaard Christensen; Harald Illges; Niels Odum; Tord Labuda
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

3.  Transcriptional regulation of Tlr11 gene expression in epithelial cells.

Authors:  Zhenyu Cai; Zhongcheng Shi; Amir Sanchez; Tingting Zhang; Mingyao Liu; Jianghua Yang; Fen Wang; Dekai Zhang
Journal:  J Biol Chem       Date:  2009-10-02       Impact factor: 5.157

4.  The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity.

Authors:  Adam C Silver; Alvaro Arjona; Wendy E Walker; Erol Fikrig
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

5.  The cell-specific induction of CXC chemokine ligand 9 mediated by IFN-gamma in microglia of the central nervous system is determined by the myeloid transcription factor PU.1.

Authors:  Sally L Ellis; Vanessa Gysbers; Peter M Manders; Wen Li; Markus J Hofer; Marcus Müller; Iain L Campbell
Journal:  J Immunol       Date:  2010-06-28       Impact factor: 5.422

6.  Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.

Authors:  Claudio Fenizia; Martina Fiocchi; Kathryn Jones; Robyn Washington Parks; Michele Ceribelli; Sebastien A Chevalier; Dustin Edwards; Francis Ruscetti; Cynthia A Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

7.  Nfkb1 activation by the E26 transformation-specific transcription factors PU.1 and Spi-B promotes Toll-like receptor-mediated splenic B cell proliferation.

Authors:  Stephen K H Li; Ali K Abbas; Lauren A Solomon; Gaëlle M N Groux; Rodney P DeKoter
Journal:  Mol Cell Biol       Date:  2015-03-02       Impact factor: 4.272

Review 8.  Mechanisms regulating dendritic cell specification and development.

Authors:  Stephanie S Watowich; Yong-Jun Liu
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

9.  Nuclear factor kappaB (NF-kappaB) activation primes cells to a pro-inflammatory polarized response to a Toll-like receptor 7 (TLR7) agonist.

Authors:  Jongdae Lee; Masaaki Hayashi; Jeng-Fan Lo; Colleen Fearns; Wen-Ming Chu; Yunping Luo; Rong Xiang; Tsung-Hsien Chuang
Journal:  Biochem J       Date:  2009-06-26       Impact factor: 3.857

10.  TLR3 drives IRF6-dependent IL-23p19 expression and p19/EBI3 heterodimer formation in keratinocytes.

Authors:  Divya Ramnath; Kathryn Tunny; Daniel M Hohenhaus; Claire M Pitts; Anne-Sophie Bergot; P Mark Hogarth; John A Hamilton; Ronan Kapetanovic; Richard A Sturm; Glen M Scholz; Matthew J Sweet
Journal:  Immunol Cell Biol       Date:  2015-08-25       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.